A-to-I edited miR-411-5p targets MET and promotes TKI response in NSCLC-resistant cells. Romano G, Le P, Nigita G, Saviana M, et al. Oncogene 2023;42:1597-1606.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Romano G, Le P, Nigita G, Saviana M, et al. A-to-I edited miR-411-5p targets MET and promotes TKI response in NSCLC-resistant cells. Oncogene 2023;42:1597-1606.
PMID: 37002315